NEW Selling losers for tax season? Check the wash-sale window first
Our free Wash Sale Calculator shows the first day you can buy back — and flags buys that would cancel your tax loss.
Check a trade »

Waters Corporation WAT | NYSE

$480.01 $3.13 | 0.66%
TREND SIGNAL:Signal available — unlock to view |2026-10-15

Next Earnings: Nov 03, 2026

Company Overview:

Market Cap: $47.18B
Trailing PE: 119.7x
FWD PE *: 30.7x
Payout Ratio (TTM): 0.0%
52-Week Range: $282.77 - $482.28

* Forward PE is based on street estimates.

10 Year WAT Performance Metrics:

Total Return (with DRIP): 245.0% (13.18% CAGR)
Total Return (no DRIP): 245.0% (13.18% CAGR)
Share Price: 243.3% (13.13% CAGR)
Yield on Cost (with DRIP): 0.11%
Total Invested: $10,000
Total Value (with DRIP): $34,498
Total Return $ (with DRIP): $24,498
Dividend Increase: N/A (0.00% CAGR)
Dividend Yield (FWD): 0.03% ($0.16)
WAT 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
WAT Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
WAT Price CAGR:1Y: 39.75%2Y: 21.59%5Y: 5.48%10Y: 13.13%
WAT Dividend Charts
WAT - Dividends
WAT Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
WAT - Dividend Payout Ratio
WAT Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Dividend to Free Cash Flow Ratio
WAT Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Build Custom Charts
WAT - Chart 1
WAT - Chart 2
WAT - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

WAT Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

WAT - Revenue
WAT Revenue CAGR:1Y: 113.27%2Y: 52.37%5Y: 19.27%10Y: 11.85%
WAT - Earnings Per Share (EPS)
WAT EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Net Income
🔓 See the full chart40% off right now · 7-day free trial
WAT Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
WAT EBITDA CAGR:1Y: -11.77%2Y: -4.63%5Y: -2.10%10Y: 3.39%
WAT - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
WAT Free Cash Flow CAGR:1Y: 714.15%2Y: 186.24%5Y: 8.89%10Y: 1.36%
WAT - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
WAT Free Cash Flow / Share CAGR:1Y: 399.94%2Y: 123.97%5Y: -0.52%10Y: -0.47%
WAT - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
WAT Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
WAT Gross Profit CAGR:1Y: 63.14%2Y: 34.19%5Y: 12.83%10Y: 8.79%
WAT - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
WAT Shares Outstanding CAGR:1Y: 64.62%2Y: 28.52%5Y: 9.58%10Y: 1.89%
WAT - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
WAT Share Buybacks CAGR:1Y: 433.33%2Y: 185.71%5Y: -58.79%10Y: -30.58%
WAT - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
WAT Stock-Based Comp CAGR:1Y: 90.88%2Y: 47.87%5Y: 27.95%10Y: 11.53%
WAT - Expenses
🔓 See the full chart40% off right now · 7-day free trial
WAT Expenses CAGR:1Y: 116.87%2Y: 16.50%5Y: 2.00%10Y: 6.94%
WAT - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
WAT - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
WAT - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
WAT - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
WAT - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
WAT - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
WAT - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
WAT Revenue CAGR:1Y: 113.27%2Y: 52.37%5Y: 19.27%10Y: 11.85%
WAT - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
WAT Revenue CAGR:1Y: 113.27%2Y: 52.37%5Y: 19.27%10Y: 11.85%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

WAT - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
WAT Actual Revenue CAGR:1Y: 113.27%2Y: 52.37%5Y: 19.27%10Y: 11.85%
WAT - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
WAT Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
WAT Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
WAT Actual EBITDA CAGR:1Y: -11.77%2Y: -4.63%5Y: -2.10%10Y: 3.39%

Ratios, Profit Margins & Return on Capital:

WAT - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
WAT Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
WAT Gross Profit Margin CAGR:1Y: -23.50%2Y: -11.93%5Y: -5.40%10Y: -2.74%
WAT - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
WAT Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
WAT Price To Sales Ratio CAGR:1Y: -16.73%2Y: -3.46%5Y: -6.78%10Y: 0.57%
WAT - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
WAT Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
WAT Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

WAT Dividends Info:

Annual Dividend: $0.16
Forward Yield: 0.03%
Ex-Dividend Date: 1996-11-26
Lifetime Dividends / Share: $0.04

WAT Dividend History: Dates, Payments & Yield list

Below is a schedule of all WAT dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
11/26/199611/28/1996$0.0402.37%2.36%$6.78

Projected Future Returns & Dividends for WAT

Based on past 10-year performance, here are WAT growth metrics:

Share price CAGR of +13.13%
Dividend CAGR of +0%

Using WAT CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

WAT (DRIP)WAT - No DRIP
Current Price$480.01$480.01
Start Shares20.8320.83
Start Value$10,000$10,000
  
After 10 years:
Final Share Count20.9020.83
Dividends Payment$0.04$0.04
Annual Dividends$3$3
Yield on cost0.03%0.03%
Share Price$480.01$480.01
Total Dividends$33$33
Final Value$10,033$10,033

Estimated Future Value + Dividends - WAT

NOTE: Above numbers are our estimate based on WAT's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Waters Corporation (WAT) had its IPO on 1995-11-17, and is traded on NYSE stock exchange.

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

WAT website: https://www.waters.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — WAT

Value from:
Pay up to today
—
vs current price $480.01
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →